Programs
Oritavex
OncologyADC therapy for HER2-low metastatic breast cancer
Manufacturer: Luminos TherapeuticsHub: CarePoint Hub ServicesLaunched: Jun 15, 2025
85
Healthy
Active Cases
39
Completed
13
Stalled
8
21% stall rate
Handoff Stalls
2
Across all transitions
Status Pipeline
5
Referral
13%
8
Benefits
21%
5
Prior Auth
13%
5
Enrollment
13%
8
Fulfillment
21%
8
Outcome
21%
Cases
Case Ref | Status | Time in Status | SLA | Responsible | Updated |
|---|---|---|---|---|---|
| REF-2025-0988 | EnrollmentPatient Enrolled | 1h | On Track | Patient | Feb 6 |
| REF-2026-1008 | FulfillmentShipped | 6h | On Track | Specialty Pharmacy | Feb 3 |
| REF-2026-0998 | OutcomeOngoing Therapy | 1d | Approaching SLA | Patient | Jan 31 |
| REF-2025-1011 | FulfillmentShipped | 8h | On Track | Specialty Pharmacy | Jan 29 |
| REF-2026-0984 | FulfillmentDelivered | 1h | On Track | Specialty Pharmacy | Jan 28 |
| REF-2026-1003 | EnrollmentPatient Enrollment Started | 15h | On Track | Hub Services | Jan 28 |
| REF-2025-0993 | FulfillmentDelivered | 2h | On Track | Specialty Pharmacy | Jan 25 |
| REF-2025-1005 | Prior AuthPA Submitted | 3d | Approaching SLA | Payer | Jan 25 |
| REF-2025-1020 | EnrollmentPatient Enrollment Started | 3d | SLA Exceeded | Hub Services | Jan 18 |
| REF-2025-1004 | OutcomeOngoing Therapy | 3d | SLA Exceeded | Patient | Jan 17 |
| REF-2025-0997 | BenefitsBI Complete | 2d | Approaching SLA | Payer | Jan 15 |
| REF-2026-1016 | OutcomeFirst Fill Complete | 6d | On Track | Patient | Jan 12 |
| REF-2025-1017 | Prior AuthPA Denied — Final | 1h | On Track | Payer | Jan 6 |
| REF-2025-0994 | OutcomeFirst Fill Complete | 2d | On Track | Patient | Jan 3 |
| REF-2025-0985 | ReferralReferral Validated | 1d | SLA Exceeded | Specialty Pharmacy | Jan 2 |
| REF-2025-0996 | ReferralReferral Validated | 4h | On Track | Specialty Pharmacy | Jan 2 |
| REF-2025-0999 | OutcomeFirst Fill Complete | 26d | Approaching SLA | Patient | Jan 2 |
| REF-2025-1021 | FulfillmentShipped | 1d | On Track | Specialty Pharmacy | Jan 2 |
| REF-2025-0986 | BenefitsBI Initiated | 5h | On Track | Specialty Pharmacy | Jan 1 |
| REF-2025-0995 | BenefitsBI Initiated | 1d | Approaching SLA | Specialty Pharmacy | Jan 1 |
| REF-2025-1013 | FulfillmentRx Processing | 15h | On Track | Specialty Pharmacy | Jan 1 |
| REF-2025-1001 | FulfillmentRx Processing | 2d | SLA Exceeded | Specialty Pharmacy | Dec 31 |
| REF-2025-1014 | EnrollmentPatient Enrolled | 5d | SLA Exceeded | Patient | Dec 31 |
| REF-2025-1010 | OutcomeFirst Fill Complete | 54d | SLA Exceeded | Patient | Dec 24 |
| REF-2025-0992 | Prior AuthPA Denied — Final | 1d | Approaching SLA | Payer | Dec 22 |
| REF-2025-1012 | ReferralReferral Validated | 9h | Approaching SLA | Specialty Pharmacy | Dec 18 |
| REF-2025-1022 | BenefitsBI Initiated | 23h | Approaching SLA | Specialty Pharmacy | Dec 17 |
| REF-2025-0991 | ReferralReferral Validated | 3h | On Track | Specialty Pharmacy | Dec 12 |
| REF-2025-1015 | BenefitsBI Complete | 1d | On Track | Payer | Dec 12 |
| REF-2025-1018 | BenefitsBI Initiated | 11h | On Track | Specialty Pharmacy | Dec 11 |
| REF-2025-0989 | BenefitsBI Complete | 4d | SLA Exceeded | Payer | Dec 9 |
| REF-2025-0987 | Prior AuthPA Denied — Appeal | 5d | Approaching SLA | Payer | Dec 3 |
| REF-2025-1009 | BenefitsBI Complete | 9h | On Track | Payer | Nov 29 |
| REF-2025-0990 | Prior AuthPA Submitted | 14h | On Track | Payer | Nov 26 |
| REF-2025-1006 | ReferralReferral Validated | 3h | On Track | Specialty Pharmacy | Nov 24 |
| REF-2025-1002 | OutcomeFirst Fill Complete | 63d | SLA Exceeded | Patient | Nov 22 |
| REF-2025-1007 | FulfillmentDelivered | 12h | On Track | Specialty Pharmacy | Nov 21 |
| REF-2025-1019 | OutcomeOngoing Therapy | 23h | Approaching SLA | Patient | Nov 21 |
| REF-2025-1000 | EnrollmentPatient Enrollment Started | 20h | Approaching SLA | Hub Services | Nov 10 |
Stall Breakdown
BI Complete → PA Submitted
1 case stalled
Expected: 1dActual: 3d
Specialty Pharmacy: 1
Patient Enrollment Started → Patient Enrolled
1 case stalled
Expected: 2dActual: 9d
Patient: 1